Maxposure Limited (NSE:MAXPOSURE)
India · Delayed Price · Currency is INR 29.00
-1.15 (-3.81%)
Oct 23, 2026, 3:20 PM IST
Maxposure Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 880.24 | 632.82 | 472.78 | 317.89 | 326.8 | |
Revenue Growth | 39.10% | 33.85% | 48.72% | -2.73% | 62.11% |
Cost of Revenue | 528.16 | 311.37 | 198.87 | 128.4 | 62.68 |
Gross Profit | 352.08 | 321.45 | 273.9 | 189.5 | 264.12 |
Selling, General & Admin | 168.09 | 177.86 | 144.15 | 93.94 | 232.95 |
Other Operating Expenses | 52.44 | 35.57 | 21.71 | 41.3 | 23.88 |
Operating Expenses | 229.6 | 221.05 | 171.23 | 138.88 | 260.01 |
Operating Income | 122.48 | 100.4 | 102.67 | 50.62 | 4.12 |
Interest Expense | -7.98 | -1.48 | -4.69 | -6.54 | -3.36 |
Interest & Investment Income | 6.72 | 12.68 | 7.16 | 6.87 | 1.4 |
Currency Exchange Gain (Loss) | -1.26 | 0 | 0.3 | 0.5 | 0.51 |
Other Non Operating Income (Expenses) | -1.89 | -1.63 | -0.53 | -1.19 | -2.08 |
EBT Excluding Unusual Items | 118.08 | 109.97 | 104.92 | 50.25 | 0.58 |
Gain (Loss) on Sale of Assets | - | - | 0.47 | 0.31 | 1.87 |
Other Unusual Items | - | - | 8.85 | 9.99 | 1.55 |
Pretax Income | 118.08 | 109.97 | 114.24 | 60.55 | 4.01 |
Income Tax Expense | 23.32 | 24.96 | 33.18 | 15.73 | 0.51 |
Net Income | 94.75 | 85.01 | 81.06 | 44.82 | 3.5 |
Net Income to Common | 94.75 | 85.01 | 81.06 | 44.82 | 3.5 |
Net Income Growth | 11.46% | 4.88% | 80.86% | 1181.95% | -3.48% |
Shares Outstanding (Basic) | 23 | 23 | 23 | 17 | 17 |
Shares Outstanding (Diluted) | 23 | 23 | 23 | 17 | 17 |
Shares Change | - | - | 36.99% | - | - |
EPS (Basic) | 4.17 | 3.74 | 3.56 | 2.70 | 0.21 |
EPS (Diluted) | 4.17 | 3.74 | 3.56 | 2.70 | 0.21 |
EPS Growth | 11.46% | 5.00% | 31.87% | 1181.95% | -3.48% |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | -35.52 | -225.1 | -16.9 | -8.78 | 9.54 |
Free Cash Flow Per Share | -1.56 | -9.90 | -0.74 | -0.53 | 0.57 |
Gross Margin | 40.00% | 50.80% | 57.94% | 59.61% | 80.82% |
Operating Margin | 13.91% | 15.87% | 21.72% | 15.92% | 1.26% |
Profit Margin | 10.76% | 13.43% | 17.14% | 14.10% | 1.07% |
Free Cash Flow Margin | -4.04% | -35.57% | -3.57% | -2.76% | 2.92% |
EBITDA | 131.56 | 108.03 | 107.86 | 54.01 | 7.08 |
EBITDA Margin | 14.95% | 17.07% | 22.81% | 16.99% | 2.17% |
D&A For EBITDA | 9.08 | 7.64 | 5.19 | 3.39 | 2.96 |
EBIT | 122.48 | 100.4 | 102.67 | 50.62 | 4.12 |
EBIT Margin | 13.91% | 15.87% | 21.72% | 15.92% | 1.26% |
Effective Tax Rate | 19.75% | 22.70% | 29.04% | 25.98% | 12.80% |
Revenue as Reported | 887.6 | 646.3 | 481.44 | 335.56 | 332.14 |
Advertising Expenses | 5.44 | 1.4 | 10.83 | 15.47 | 43.73 |